{"hands_on_practices": [{"introduction": "The Cori cycle is a classic example of inter-organ metabolic cooperation, linking anaerobic glycolysis in the muscles to gluconeogenesis in the liver. This metabolic loop is crucial during intense exercise, but it is not without a physiological cost. This practice invites you to perform a detailed stoichiometric and energetic accounting to precisely calculate the net ATP expenditure for the organism to run this cycle, reinforcing your understanding of the energy budgets of central metabolic pathways [@problem_id:2573745].", "problem": "A human engages in brief, intense exercise in which skeletal muscle operates anaerobically and converts circulating glucose to lactate. The lactate is exported to the liver, which is in a gluconeogenic state and synthesizes glucose that is returned to the muscle. This constitutes one turn of the Cori cycle. Using mass balance, redox balance, and energy bookkeeping grounded in well-tested pathway stoichiometries, derive the net organism-level adenosine triphosphate (ATP) cost of operating the Cori cycle per mole of glucose cycled from liver to muscle and back as lactate.\n\nAssumptions:\n- All reactions occur under standard biochemical conditions at cytosolic pH $7.0$.\n- Transport costs between tissues are negligible.\n- Count one guanosine triphosphate (GTP) hydrolyzed as one ATP equivalent (one high-energy phosphate bond).\n- Nicotinamide adenine dinucleotide (NADH) produced by hepatic lactate oxidation is available to support gluconeogenic reductions; do not credit any oxidative phosphorylation.\n- Use the following widely accepted net stoichiometries as foundational facts:\n  - Anaerobic glycolysis in muscle (glucose to lactate):\n    $$\\mathrm{glucose} + 2\\,\\mathrm{ADP} + 2\\,\\mathrm{P_i} \\rightarrow 2\\,\\mathrm{lactate} + 2\\,\\mathrm{ATP} + 2\\,\\mathrm{H_2O}.$$\n  - Lactate dehydrogenase (reversible):\n    $$\\mathrm{lactate} + \\mathrm{NAD^+} \\leftrightarrow \\mathrm{pyruvate} + \\mathrm{NADH} + \\mathrm{H^+}.$$\n  - Hepatic gluconeogenesis from pyruvate to glucose consumes high-energy phosphates at pyruvate carboxylase, phosphoenolpyruvate carboxykinase, and phosphoglycerate kinase and requires reducing equivalents at glyceraldehyde-$3$-phosphate dehydrogenase; in aggregate for $2$ pyruvate to $1$ glucose it uses $4$ ATP, $2$ GTP, and $2$ NADH.\n\nTask:\n- Starting from the above foundations and enforcing conservation of carbon, charge, and reducing equivalents, sum the muscle and liver reactions to obtain the overall organism-level balance for one mole of glucose cycled through the Cori cycle.\n- From this overall balance, compute the net number of ATP equivalents consumed per mole of glucose cycled.\n\nAnswer format:\n- Express the final result as a single number representing moles of ATP equivalents per mole of glucose cycled. No rounding is necessary.", "solution": "The problem requires the derivation of the net organism-level adenosine triphosphate (ATP) cost for one turn of the Cori cycle. This will be accomplished by analyzing the stoichiometry of the processes in the muscle and the liver, and then summing them to find the overall net reaction and its associated energy cost. The analysis will adhere strictly to the provided stoichiometries and assumptions, including mass balance, redox balance, and energy bookkeeping where $1$ mole of guanosine triphosphate (GTP) is considered equivalent to $1$ mole of ATP.\n\nFirst, we analyze the metabolic process occurring in the skeletal muscle. During intense exercise, the muscle operates anaerobically, converting glucose to lactate. The problem provides the net reaction for this process:\n$$ \\mathrm{glucose} + 2\\,\\mathrm{ADP} + 2\\,\\mathrm{P_i} \\rightarrow 2\\,\\mathrm{lactate} + 2\\,\\mathrm{ATP} + 2\\,\\mathrm{H_2O} $$\nFrom this stoichiometry, we observe that for each mole of $\\mathrm{glucose}$ consumed, the muscle tissue produces a net of $2$ moles of $\\mathrm{ATP}$. The $2$ moles of lactate produced are then transported to the liver.\n\nSecond, we analyze the metabolic process occurring in the liver, which is in a gluconeogenic state. The liver takes up the $2$ moles of lactate from the circulation and synthesizes $1$ mole of $\\mathrm{glucose}$. This conversion can be considered in two sequential stages:\n1.  The oxidation of lactate to pyruvate, catalyzed by lactate dehydrogenase. For $2$ moles of lactate, this reaction is:\n    $$ 2\\,\\mathrm{lactate} + 2\\,\\mathrm{NAD^+} \\rightarrow 2\\,\\mathrm{pyruvate} + 2\\,\\mathrm{NADH} + 2\\,\\mathrm{H^+} $$\n    This reaction produces $2$ moles of the reducing equivalent $\\mathrm{NADH}$.\n\n2.  The synthesis of glucose from pyruvate (gluconeogenesis). The problem states that the conversion of $2$ moles of pyruvate into $1$ mole of $\\mathrm{glucose}$ consumes $4$ moles of $\\mathrm{ATP}$, $2$ moles of $\\mathrm{GTP}$, and $2$ moles of $\\mathrm{NADH}$.\n\nCombining these two stages for the overall process in the liver (from $2$ lactate to $1$ glucose), we can account for the redox balance. The $2$ moles of $\\mathrm{NADH}$ produced in the first stage are consumed in the second stage. As specified in the problem, this internal balancing means there is no net production or consumption of $\\mathrm{NADH}$ by the liver for the overall transformation of lactate to glucose, and no interaction with oxidative phosphorylation is considered.\nThe net energetic cost in the liver is therefore the sum of the high-energy phosphate bonds hydrolyzed. Using the given equivalence of $1\\,\\mathrm{GTP} = 1\\,\\mathrm{ATP}$, the total cost is calculated as:\n$$ \\text{Hepatic Cost} = 4\\,\\mathrm{ATP} + 2\\,\\mathrm{GTP} = 4\\,\\text{ATP equivalents} + 2\\,\\text{ATP equivalents} = 6\\,\\text{ATP equivalents} $$\nThus, the liver consumes a net of $6$ moles of ATP equivalents to regenerate $1$ mole of $\\mathrm{glucose}$ from the $2$ moles of lactate supplied by the muscle. The net reaction for the liver can be written as:\n$$ 2\\,\\mathrm{lactate} + 4\\,\\mathrm{ATP} + 2\\,\\mathrm{GTP} \\rightarrow \\mathrm{glucose} + 4\\,\\mathrm{ADP} + 2\\,\\mathrm{GDP} + 6\\,\\mathrm{P_i} $$\n(Water and proton balance is omitted as it does not affect the ATP calculation).\n\nFinally, to determine the net cost for the entire organism for one complete Cori cycle, we sum the energetic balance of the muscle and the liver. The cycle consists of $\\mathrm{glucose}$ being converted to $\\mathrm{lactate}$ in the muscle and $\\mathrm{lactate}$ being converted back to $\\mathrm{glucose}$ in the liver.\n-   ATP production in muscle: $+2$ moles of $\\mathrm{ATP}$\n-   ATP equivalent consumption in liver: $-6$ moles of $\\mathrm{ATP}$ equivalents\n\nThe net organism-level change in ATP equivalents is the sum of these two values:\n$$ \\text{Net ATP equivalent change} = (+2\\,\\mathrm{ATP}) + (-6\\,\\text{ATP equivalents}) = -4\\,\\text{ATP equivalents} $$\nThe negative sign indicates a net consumption of ATP equivalents by the organism. Therefore, the net cost of operating one turn of the Cori cycle is $4$ moles of ATP equivalents per mole of glucose cycled.\n\nTo formalize this, we sum the net reactions for the muscle and liver:\nMuscle: $\\mathrm{glucose} + 2\\,\\mathrm{ADP} + 2\\,\\mathrm{P_i} \\rightarrow 2\\,\\mathrm{lactate} + 2\\,\\mathrm{ATP} + 2\\,\\mathrm{H_2O}$\nLiver: $2\\,\\mathrm{lactate} + 4\\,\\mathrm{ATP} + 2\\,\\mathrm{GTP} \\rightarrow \\mathrm{glucose} + 4\\,\\mathrm{ADP} + 2\\,\\mathrm{GDP} + 6\\,\\mathrm{P_i}$\nSumming these two equations and canceling the terms that appear on both sides ($\\mathrm{glucose}$ and $2\\,\\mathrm{lactate}$), we get the overall net reaction for the cycle:\n$$ 2\\,\\mathrm{ADP} + 2\\,\\mathrm{P_i} + 4\\,\\mathrm{ATP} + 2\\,\\mathrm{GTP} \\rightarrow 2\\,\\mathrm{ATP} + 2\\,\\mathrm{H_2O} + 4\\,\\mathrm{ADP} + 2\\,\\mathrm{GDP} + 6\\,\\mathrm{P_i} $$\nSimplifying this equation by canceling like terms on opposite sides yields:\n$$ 2\\,\\mathrm{ATP} + 2\\,\\mathrm{GTP} \\rightarrow 2\\,\\mathrm{ADP} + 2\\,\\mathrm{GDP} + 4\\,\\mathrm{P_i} + 2\\,\\mathrm{H_2O} $$\nThis final net reaction shows that the overall process of the Cori cycle is the hydrolysis of $2$ moles of $\\mathrm{ATP}$ and $2$ moles of $\\mathrm{GTP}$. The total cost in ATP equivalents is the sum of these high-energy phosphate bonds consumed:\n$$ \\text{Net Cost} = 2\\,\\mathrm{ATP} + 2\\,\\mathrm{GTP} = 2 + 2 = 4\\,\\text{ATP equivalents} $$\nThe net cost to the organism for running the Cori cycle is $4$ ATP equivalents per mole of glucose cycled.", "answer": "$$\\boxed{4}$$", "id": "2573745"}, {"introduction": "During fasting, the liver becomes a central hub for fatty acid metabolism, facing a critical decision: either oxidize fatty acids for energy and ketone body production or re-esterify them for export as triglycerides in VLDL particles. This decision point, governed by the enzyme CPT1, is a master regulator of systemic lipid homeostasis. This exercise challenges you to apply the principle of flux conservation to predict how pharmacologically inhibiting one branch of this metabolic crossroads forces a redirection of metabolic traffic down the alternative route [@problem_id:2573686].", "problem": "A human subject in the post-absorptive to early-fasted state has elevated delivery of non-esterified long-chain fatty acids to the liver. Consider the following steady-state flux partition of hepatic long-chain fatty acyl-coenzyme A: let $J_{\\text{in}}$ be the influx of long-chain fatty acids into hepatocytes; $J_{\\text{mit}}$ be the flux of long-chain fatty acyl-coenzyme A into mitochondria for $\\beta$-oxidation via Carnitine Palmitoyltransferase 1 (CPT1); $J_{\\text{TG}}$ be the flux of long-chain fatty acyl-coenzyme A into re-esterification to triglyceride destined for Very Low Density Lipoprotein (VLDL) secretion; and $J_{\\text{other}}$ summarize all minor fates. Assume peroxisomal oxidation and $J_{\\text{other}}$ are small and unchanged over the time frame considered, and that apolipoprotein B availability and microsomal triglyceride transfer protein activity are not rate limiting. In the fasting state, mitochondrial acetyl-coenzyme A produced by $\\beta$-oxidation is a principal substrate for hepatic ketogenesis.\n\nAn acute, liver-targeted CPT1 inhibitor is administered that selectively lowers $J_{\\text{mit}}$ without altering adipose lipolysis or plasma long-chain fatty acid supply, and without directly affecting apolipoprotein synthesis. Using flux conservation and the requirement for mitochondrial entry for $\\beta$-oxidation, predict the most likely direction of change in hepatic ketone body output and VLDL triglyceride secretion during the acute effect window, and justify based on the partitioning of $J_{\\text{in}}$ among fates.\n\nWhich option best captures the expected paired response?\n\nA. Ketogenesis decreases; VLDL triglyceride secretion increases.\n\nB. Ketogenesis decreases; VLDL triglyceride secretion decreases.\n\nC. Ketogenesis increases; VLDL triglyceride secretion decreases.\n\nD. Ketogenesis increases; VLDL triglyceride secretion increases.", "solution": "The core of this problem lies in the principle of conservation of metabolic flux. In a steady state, the total influx of a substrate into a metabolic pool must equal the total efflux from that pool. For the hepatic pool of long-chain fatty acyl-coenzyme A (LCFA-CoA), the balance equation is:\n$$J_{\\text{in}} = J_{\\text{mit}} + J_{\\text{TG}} + J_{\\text{other}}$$\nThe problem specifies that the influx ($J_{\\text{in}}$) and minor fates ($J_{\\text{other}}$) are constant. The CPT1 inhibitor causes a decrease in the mitochondrial flux, $J_{\\text{mit}}$. To maintain the balance, the flux must be redirected. Thus, the decrease in $J_{\\text{mit}}$ must be compensated by an increase in the flux towards triglyceride re-esterification, $J_{\\text{TG}}$. Since VLDL assembly is not limiting, an increase in $J_{\\text{TG}}$ directly leads to an **increase in VLDL triglyceride secretion**.\n\nFor ketogenesis, the substrate is mitochondrial acetyl-CoA, which is produced by $\\beta$-oxidation. The rate of $\\beta$-oxidation is determined by the flux of fatty acids into the mitochondria, $J_{\\text{mit}}$. Since the CPT1 inhibitor decreases $J_{\\text{mit}}$, the rate of $\\beta$-oxidation and subsequent acetyl-CoA production will fall. This reduced substrate supply for ketogenesis will cause hepatic **ketogenesis to decrease**.\n\nTherefore, the combined effect is a decrease in ketogenesis and an increase in VLDL triglyceride secretion. This corresponds to option A.", "answer": "$$\\boxed{A}$$", "id": "2573686"}, {"introduction": "The metabolic state of a cell is profoundly influenced by its redox potential, especially the balance between $NADH$ and $NAD^{+}$. This ratio acts as a sensitive indicator of cellular energy status and directly regulates the activity of numerous dehydrogenases in key pathways. This advanced problem asks you to trace the cascading consequences of disrupting mitochondrial redox balance, integrating your knowledge of the electron transport chain, inter-compartmental shuttles, gluconeogenesis, and ketogenesis to predict the systemic metabolic outcome [@problem_id:2573752].", "problem": "A hepatocyte-rich liver preparation is studied under fasting-mimicking conditions with abundant long-chain fatty acids and lactate provided as substrates. An acute, specific inhibition of mitochondrial respiratory chain Complex I (nicotinamide adenine dinucleotide dehydrogenase) is applied, while Complex III and Complex IV remain fully functional and oxygen delivery is not limiting. Consider the following foundational facts and definitions as the starting point for your reasoning:\n- The Electron Transport Chain (ETC) oxidizes matrix $\\mathrm{NADH}$ at Complex I to regenerate matrix $\\mathrm{NAD^+}$ and transfers electrons to the ubiquinone pool, then through Complex III and Complex IV to oxygen.\n- The Tricarboxylic Acid (TCA) cycle and multiple dehydrogenases are sensitive to the matrix redox state, with high matrix $\\mathrm{NADH}:\\mathrm{NAD^+}$ suppressing $\\mathrm{NAD^+}$-dependent steps.\n- The Malate–Aspartate Shuttle (MAS) normally reoxidizes cytosolic $\\mathrm{NADH}$ by reducing cytosolic oxaloacetate to malate, transporting malate into the matrix, and reoxidizing malate to oxaloacetate in the matrix with reduction of matrix $\\mathrm{NAD^+}$ to $\\mathrm{NADH}$.\n- The Glycerol-3-Phosphate (G3P) shuttle reoxidizes cytosolic $\\mathrm{NADH}$ via cytosolic glycerol-3-phosphate dehydrogenase, passes electrons to mitochondrial inner-membrane glycerol-3-phosphate dehydrogenase (flavin adenine dinucleotide dependent), and donates electrons to ubiquinone, thereby bypassing Complex I.\n- Lactate dehydrogenase catalyzes $\\mathrm{lactate} + \\mathrm{NAD^+} \\leftrightarrow \\mathrm{pyruvate} + \\mathrm{NADH} + \\mathrm{H^+}$ in the cytosol, so the cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratio biases the direction of the reaction and thereby influences gluconeogenesis from lactate (Cori cycle input).\n- Hepatic ketogenesis requires mitochondrial acetyl–coenzyme A and proceeds via condensation to acetoacetyl–coenzyme A and 3–hydroxy-3–methylglutaryl–coenzyme A; the conversion of acetoacetate to $\\beta$-hydroxybutyrate depends on the mitochondrial $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratio via $\\beta$-hydroxybutyrate dehydrogenase. The rate of long-chain fatty acid $\\beta$-oxidation depends on an $\\mathrm{NAD^+}$-dependent step (hydroxyacyl–coenzyme A dehydrogenase).\n\nBased only on these principles, predict the most accurate combined effects of acute Complex I inhibition on:\n- the mitochondrial matrix $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratio,\n- the cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratio given the interplay of MAS and the G3P shuttle,\n- hepatic gluconeogenesis from lactate,\n- total hepatic ketone body production.\n\nChoose the single best option.\n\nA. Matrix $\\mathrm{NADH}:\\mathrm{NAD^+}$ increases; cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ increases; gluconeogenesis from lactate decreases; total ketone production decreases.\n\nB. Matrix $\\mathrm{NADH}:\\mathrm{NAD^+}$ decreases; cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ decreases; gluconeogenesis from lactate increases; total ketone production increases.\n\nC. Matrix $\\mathrm{NADH}:\\mathrm{NAD^+}$ increases; cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ decreases due to dominant G3P shuttle; gluconeogenesis from lactate increases; total ketone production increases.\n\nD. Matrix $\\mathrm{NADH}:\\mathrm{NAD^+}$ increases; cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ unchanged due to complete shuttle compensation; gluconeogenesis from lactate unchanged; total ketone production increases.\n\nE. Matrix $\\mathrm{NADH}:\\mathrm{NAD^+}$ increases; cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ increases; gluconeogenesis from lactate decreases; total ketone production unchanged, but the $\\beta$-hydroxybutyrate:acetoacetate ratio increases.", "solution": "This problem requires deducing the systemic metabolic consequences of acute, specific inhibition of mitochondrial respiratory chain Complex I. We will analyze the effects on the four specified parameters step-by-step based on the provided principles.\n\n1.  **Effect on the mitochondrial matrix $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratio:**\n    Complex I is the primary pathway for oxidizing mitochondrial $\\mathrm{NADH}$ to regenerate $\\mathrm{NAD^+}$. Under fasting conditions, $\\beta$-oxidation and the TCA cycle produce large amounts of $\\mathrm{NADH}$. Inhibiting Complex I blocks the main exit route for these reducing equivalents, causing $\\mathrm{NADH}$ to accumulate and $\\mathrm{NAD^+}$ to be depleted. Consequently, the mitochondrial matrix $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratio **increases** dramatically.\n\n2.  **Effect on total hepatic ketone body production:**\n    The high matrix $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratio inhibits $\\mathrm{NAD^+}$-dependent enzymes, including key dehydrogenases in the $\\beta$-oxidation pathway. This slows down fatty acid oxidation, reducing the rate of acetyl-CoA production. Since acetyl-CoA is the obligate precursor for ketogenesis, the overall rate of ketone body synthesis will **decrease**.\n\n3.  **Effect on the cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratio:**\n    The liver reoxidizes cytosolic $\\mathrm{NADH}$ mainly via the high-capacity Malate–Aspartate Shuttle (MAS), which depends on a functioning Complex I. With Complex I inhibited and the matrix redox state highly reduced, the MAS is effectively shut down. The alternative, lower-capacity Glycerol-3-Phosphate (G3P) shuttle is insufficient to handle the cytosolic $\\mathrm{NADH}$ produced (e.g., from lactate oxidation). This leads to an accumulation of cytosolic $\\mathrm{NADH}$, causing the cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratio to **increase**.\n\n4.  **Effect on hepatic gluconeogenesis from lactate:**\n    The conversion of lactate to pyruvate, the first step for gluconeogenesis from this substrate, is catalyzed by lactate dehydrogenase and requires $\\mathrm{NAD^+}$. The increased cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratio (as determined in point 3) shifts the equilibrium of this reaction away from pyruvate formation. The reduced supply of pyruvate thereby inhibits the overall flux through gluconeogenesis. Therefore, gluconeogenesis from lactate **decreases**.\n\nCombining these four conclusions, we find that the matrix and cytosolic $\\mathrm{NADH}:\\mathrm{NAD^+}$ ratios increase, while both gluconeogenesis from lactate and total ketone production decrease. This matches option A.", "answer": "$$\\boxed{A}$$", "id": "2573752"}]}